Akhil Santhosh, a Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“Addition of anti-PD1/CLTLA-4 bispecific antibody cadonilimab to chemotherapy significantly improves PFS and OS in advanced cancer of gastroesophageal junction (GEJ)/stomach: Compassion 15 trial.”
More posts featuring Akhil Santhosh.
